Early Cancer Detection Blood-Based Biomarker Panel Under Development by UK Consortium | GenomeWeb

NEW YORK (GenomeWeb) – Researchers working within the UK's Early Cancer Detection Consortium are developing a multi-omic blood-based biomarker panel for early cancer detection.

Unlike most cancer biomarker efforts, which typically focus on a single cancer or a specific question within a cancer type, the UK team aims to build a test capable of detecting multiple kinds of cancers, Ian Cree, a University Hospitals Coventry and Warwickshire researcher and one of the leaders of the project, told GenomeWeb.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.